Clinical Psychopharmacology is a specialized field at the intersection of psychiatry and pharmacology, devoted to understanding the effects of psychotropic medications on mental health. This discipline plays a pivotal role in the treatment of various psychiatric disorders, offering interventions that target neurotransmitter systems to alleviate symptoms. Practitioners in clinical psychopharmacology utilize evidence-based approaches to prescribe and monitor the use of psychotropic drugs, tailoring treatments to individual patient needs. The field encompasses the study of a wide range of medications, including antidepressants, antipsychotics, anxiolytics, and mood stabilizers. Monitoring side effects and adjusting medication regimens based on individual responses are critical aspects of clinical psychopharmacology. Ethical considerations, informed consent, and a comprehensive understanding of psychopathology are integral to responsible practice in this field. The evolving landscape of neuroscience and pharmacology continually informs clinical psychopharmacology, allowing for the development of novel medications and personalized treatment approaches. Collaboration between mental health professionals, pharmacologists, and researchers is essential for advancing the field and improving outcomes for individuals grappling with mental health challenges.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia